1 results
FDA-approved drugs for multiple sclerosis have no efficacy or disability data in non-Caucasian patients
-
- Journal:
- CNS Spectrums / Volume 24 / Issue 3 / June 2019
- Published online by Cambridge University Press:
- 03 January 2019, pp. 279-280
-
- Article
-
- You have access
- HTML
- Export citation